Initial data on AMV564 in patients with relapsed/refractory AML Presented ByProf. Gail Roboz, Weill Cornell Medicine, USA TrialPhase 1, AMV564-101 ConferenceEHA 2019 TypePeer-reviewed article 9 August 2019 21:18